
HXNet
Ordered peptides from HXNet? Mail in a sample (US only) and let us test it.
Test my supplyHXNet's purity-focus record is strongest in Tirzepatide and GHK-Cu, with Retatrutide adding a large but more volatile evidence base. Weakness clusters in Tesamorelin, Cagrilintide, and TB-500, where purity or fill misses and uneven batch IDs make the recent improvements less settled.
Chinese registry snippets show the ChemicalBook anchor entity was cancelled before the current sales run. The report maps the HXTNT/LaraPharma channel shift, lookalike web infrastructure, and COA files that reuse third-party lab identifiers.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including HXNet rows.
Cancel anytime
Ordered peptides from HXNet? Mail in a sample (US only) and let us test it.
Test my supply| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
23 Oct 2026 | Pass | BPC-157 HXNet | lab name | View COA | |||
23 Oct 2026 | Pass | GHK-Cu HXNet | lab name | View COA | |||
23 Oct 2026 | Pass | TB-500 HXNet | lab name | View COA | |||
13 Oct 2026 | Pass | Retatrutide HXNet | lab name | View COA | |||
12 Oct 2026 | Pass | Retatrutide HXNet | lab name | View COA | |||
24 Sep 2026 | Pass | GHK-Cu HXNet | lab name | View COA | |||
24 Sep 2026 | Pass | GHK-Cu HXNet | lab name | View COA | |||
24 Sep 2026 | Pass | CJC-1295 (No DAC) HXNet | lab name | View COA | |||
24 Sep 2026 | Pass | Retatrutide HXNet | lab name | View COA | |||
15 Aug 2026 | Pass | Sermorelin HXNet | lab name | View COA | |||
About HXNet test results from Finnrick
HXNet is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 12 peptides and 178 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible HXNet peptides in this dataset are Tirzepatide (52 tests), Semaglutide (5 tests) and BPC-157 (10 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 178 recent tests.
Ordered peptides from HXNet? Mail in a sample (US only) and let us test it.
Test my supply